Skip to main content

Bone Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • HCT Using Treosulfan for Bone Marrow Failure Diseases (BMT CTN 1904)

    Sorry, not yet accepting patients

    This is a prospective, multicenter phase II study designed to evaluate the outcomes of patients with bone marrow failure diseases (BMFD) undergoing HLA-matched related, HLA-matched unrelated, or single HLA-class 1 allele or HLA-DQB1 antigen or allele mismatched unrelated hematopoietic cell transplantation (HCT) using treosulfan-based conditioning.

    San Francisco, California and other locations

Last updated: